Literature DB >> 15741917

[The first Tunisian cardiovascular diseases register: processes and results].

H Ben Romdhane1, S Bougatef, H Skhiri, D Gharbi, M N Kafsi, A Belhani, R Mechmèche, H Haoula, R Boujnah, S Kachboura, M Hamdoun, N Achour.   

Abstract

BACKGROUND: In Tunisia, cardiovascular diseases are the leading causes of death (30%) and a few studies conducted in the population have demonstrated that the level of their risk factors is increasing. For policy makers, the health system impact of these diseases is currently a crucial issue. The National Public Health Institute has identified the implementation of a morbidity register as a priority.
METHODS: A CVD morbidity register is implemented since 2001, in 3 different geographical populations having contrasted levels of health status (Tunis, Ariana and Ben Arous). The 3 regions are covering about 2 millions inhabitants which is the fifth of the overall Tunisian population. All coronary heart events occurring among adults 25 years old and above in the 3 populations are recorded. The diagnosis of events, case fatality and classification are defined according to MONICA criteria. The data are recorded from public and private hospitals, death certificates and autopsies.
RESULTS: During the year 2001, the total number of myocardial infarction events was estimated at 942: in men, the age-standardized rates were 163.8/100000 in Tunis population vs. 161.9 in Ariana and 170.5 in Ben Arous. In women, the rates were respectively 43.4, 61.1 and 44.6. Medical causes of death registration was the most crucial problem in spite of the implementation of the death certificate designed according to WHO model. Specific surveys for clinical assessment and surveillance of risk factors were conducted in the register populations.
CONCLUSION: It is the first time that data on coronary heart disease incidence and fatality are available in Tunisia through this experience which highlights the practical difficulties experienced in registering and coding coronary events in a developing country. The data source quality should be improved and the register should be integrated in the local health system.

Entities:  

Mesh:

Year:  2004        PMID: 15741917     DOI: 10.1016/s0398-7620(04)99094-3

Source DB:  PubMed          Journal:  Rev Epidemiol Sante Publique        ISSN: 0398-7620            Impact factor:   1.019


  6 in total

1.  Six lipoprotein lipase gene polymorphisms, lipid profile and coronary stenosis in a Tunisian population.

Authors:  Lamia Rebhi; Kaouther Kchok; Asma Omezzine; Slim Kacem; Jihène Rejeb; Ibtihel Ben HadjMbarek; Radhia Belkahla; Imen Boumaiza; Amira Moussa; Nabila Ben Rejeb; Naoufel Nabli; Essia Boughzala; Ahmed Ben Abdelaziz; Ali Bouslama
Journal:  Mol Biol Rep       Date:  2012-06-24       Impact factor: 2.316

Review 2.  Growing epidemic of coronary heart disease in low- and middle-income countries.

Authors:  Thomas A Gaziano; Asaf Bitton; Shuchi Anand; Shafika Abrahams-Gessel; Adrianna Murphy
Journal:  Curr Probl Cardiol       Date:  2010-02       Impact factor: 5.200

3.  Analysis of mutations in leu tRNA gene in patients of heart diseases.

Authors:  Aziz Ud Din; Sajid Ul Ghafoor; Fazal Akbar; Naveed Akhtar; Muhammad Fiaz Khan; Zaib Ullah; Abdul Kareem
Journal:  Saudi J Biol Sci       Date:  2021-09-13       Impact factor: 4.219

4.  Burden of non-communicable diseases in Tunisia, 1990-2017: results from the global burden of disease study.

Authors:  Houyem Khiari; Rym Mallekh; Ines Cherif; Mohamed Hsairi
Journal:  Pan Afr Med J       Date:  2021-09-28

5.  PASCAR and WHF Cardiovascular Diseases Scorecard project.

Authors:  Habib Gamra; Jihene Maatoug; Jean M Fourie; Wihan Scholtz; Oana Scarlatescu; George Nel; Hassen Ghannem
Journal:  Cardiovasc J Afr       Date:  2020 Sep/Oct       Impact factor: 1.167

6.  Low erythrocyte catalase enzyme activity is correlated with high serum total homocysteine levels in Tunisian patients with acute myocardial infarction.

Authors:  Yosri Noichri; Abdelkader Chalghoum; Latifa Chkioua; Bruno Baudin; Samia Ernez; Salima Ferchichi; Abdelhédi Miled
Journal:  Diagn Pathol       Date:  2013-04-30       Impact factor: 2.644

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.